Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Alpha-1 antitrypsin deficiency

Recruiting

Registered drugNo placebo

Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

InvestigationalNo placebo

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Registered drugNo placebo

Study on the Safety of Self-Infusion Therapy with Human Alpha1-Proteinase Inhibitor for Patients with Severe Alpha-1 Antitrypsin Deficiency

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of BEAM-302 with MR0005 and GR0015 for Adults with Alpha-1 Antitrypsin Deficiency-Related Lung or Liver Disease

InvestigationalNo placebo

Ireland

Participants:18–64 years
Substances:Gr0015

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Registered drug

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Registered drug

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Alpha-1 antitrypsin deficiency

Not yet recruiting

InvestigationalNo placebo

Safety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency

InvestigationalNo placebo

Ireland

Participants:18–64 years · 65+ years

Contact Research Centre

Alpha-1 antitrypsin deficiency

Not recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of WVE-006 for Patients with Alpha-1 Antitrypsin Deficiency (AATD) Pi*ZZ

InvestigationalNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Wve-006

Contact Research Centre

Alpha-1 antitrypsin deficiency+1

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of INBRX-101 for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Human Alpha-1-Proteinase Inhibitor Immunoglobulin G Fusion Protein, Recombinant

Contact Research Centre

Alpha-1 antitrypsin deficiency+1

Not recruiting

Registered drug

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Human Alpha-1-Proteinase Inhibitor Immunoglobulin G Fusion Protein, Recombinant

Contact Research Centre

Find therapies in clinical trials near you

11 trials match your criteria

Alpha-1 antitrypsin deficiency

Efficacy and safety of human alpha1‑proteinase inhibitor weekly infusions in adults with alpha1 antitrypsin deficiency–related emphysema

Alpha-1 antitrypsin deficiency

A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

Alpha-1 antitrypsin deficiency

Study on the Safety of Self-Infusion Therapy with Human Alpha1-Proteinase Inhibitor for Patients with Severe Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency

Study on the Safety and Effectiveness of BEAM-302 with MR0005 and GR0015 for Adults with Alpha-1 Antitrypsin Deficiency-Related Lung or Liver Disease

Alpha-1 antitrypsin deficiency

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Alpha-1 antitrypsin deficiency

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

Alpha-1 antitrypsin deficiency

Study on Long-Term Safety of Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease

Alpha-1 antitrypsin deficiency

Safety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency

Study on the Safety and Tolerability of WVE-006 for Patients with Alpha-1 Antitrypsin Deficiency (AATD) Pi*ZZ

Alpha-1 antitrypsin deficiency+1

Study on Long-Term Safety of INBRX-101 for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Alpha-1 antitrypsin deficiency+1

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.